RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like

Baisong Liao1, Yan Hu, Gary Brewer

  • 1Department of Molecular Genetics, Microbiology, and Immunology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.

Insights

The RNA-binding protein IMP-3 promotes cancer cell survival by enhancing insulin-like growth factor II (IGF-II) translation. Reducing IMP-3 increases sensitivity to ionizing radiation (IR)-induced apoptosis, suggesting IMP-3 as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Ionizing radiation (IR) triggers proapoptotic gene expression, inhibiting cell survival.
  • RNA-binding proteins regulate mRNA stability and translation, influencing cellular responses to stress.
  • The oncofetal protein IMP-3 is overexpressed in malignancies and linked to tumor aggressiveness.

Purpose of the Study:

  • To investigate the role of IMP-3 in ionizing radiation (IR)-induced apoptosis.
  • To determine if IMP-3 influences cell survival pathways in response to IR.
  • To explore IMP-3 as a potential therapeutic target for enhancing cancer treatment sensitivity.

Main Methods:

  • Utilized K562 chronic myeloid leukemia cells as a model for IR-induced apoptosis.
  • Employed small interfering RNA (siRNA) to knockdown IMP-3 expression.
  • Conducted gene reporter assays to analyze IMP-3's effect on IGF-II mRNA translation.
  • Assessed the impact of recombinant insulin-like growth factor II (IGF-II) on IR-induced apoptosis in IMP-3 knockdown cells.

Main Results:

  • Knockdown of IMP-3 significantly increased K562 cell susceptibility to IR-induced apoptosis.
  • IMP-3 knockdown led to reduced insulin-like growth factor II (IGF-II) production.
  • IMP-3 was found to promote IGF-II mRNA translation via its 5' untranslated region (UTR) during apoptosis.
  • Recombinant IGF-II partially rescued the apoptotic phenotype observed after IMP-3 knockdown.

Conclusions:

  • IMP-3 promotes cancer cell survival in response to ionizing radiation (IR) partly through the insulin-like growth factor II (IGF-II) pathway.
  • IMP-3 enhances IGF-II mRNA translation, contributing to cell survival under IR stress.
  • Targeting IMP-3 could potentially sensitize chronic myeloid leukemia (CML) cells and other cancers to IR therapy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...